ACE2 and pulmonary arterial hypertension: The situation is even more dramatic in individuals already burdened with several comorbidities involving hypertension such as pulmonary hypertension, diabetes, cardiovascular and kidney disease, which share dysregulated RAAS, including decreased ACE-2 activity that is further exacerbated by SARS-CoV-2 infection.